Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Agents and Actions. Supplements|January 1, 1991
In vivo evidence for a key role of IL-1 in cartilage destruction in experimental arthritisW B van den Berg, F A van de Loo, I Otterness, et al.
The American Journal of Pathology|December 7, 2000
Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritisA S de Hooge, F A van De Loo, O J Arntz, et al.
Zeitschrift Fur Kardiologie|March 1, 1997
[Successful treatment of fulminant myocarditis with the biventricular MEDOS Assist System (MEDOS HIA-VAD)]J Martin, K Sarai, M Yoshitake, et al.
The Netherlands Journal of Surgery|June 1, 1990
Giant synovial cyst of the hip joint presenting with femoral vein compressionH W Bolhuis, T S Van der Werf, T Tjabbes, et al.
The Journal of Rheumatology|May 1, 1991
Chondrocyte nonresponsiveness of arthritic articular cartilage caused by short term immobilizationP L van Lent, F A van de Loo, L van den Bersselaar, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenanS Cuzzocrea, E Mazzon, G Calabro, et al.
The American Journal of Pathology|July 1, 1997
Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient miceF A van de Loo, S Kuiper, F H van Enckevort, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammationL A Joosten, M M Helsen, T Saxne, et al.
Arthritis and Rheumatism|February 1, 1995
Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritisF A van de Loo, L A Joosten, P L van Lent, et al.
The Thoracic and Cardiovascular Surgeon|May 8, 2001
Left ventricular reduction for idiopathic dilated cardiomyopathy as alternative to transplant--truth or dare?T Doenst, L Ahn-Veelken, C Schlensak, et al.
Pageof 10